National Academy of Medicine

Case Study: Medicaid and Public Health Collaboration in Oregon

By Jennie Bonney and Debbie I. Chang
April 24, 2017 | Discussion Paper

Oregon is one of the leading states engaged in innovative health care delivery system reform that includes population health as a central component. Collaboration among key agencies and stakeholders is an important feature of Oregon’s reform efforts, and it occurs at many levels. This case study will highlight the state’s efforts to link the Medicaid delivery system and public health system to support prevention initiatives. Oregon’s experience may be helpful to other states as they consider reforms under Medicaid to advance population health and other prevention strategies.

In Oregon, both the state Medicaid office and state Public Health Division are housed within the Oregon Health Authority (OHA). This agency encompasses all public health care purchasing programs along with health policy and public health. Under a single agency, Medicaid and public health have shared goals and many opportunities to collaborate as partners on a population health strategy designed to improve health outcomes for a geographically defined population. In the roadmap referenced above, we refer to this type of prevention strategy as population level 2 or PL-2. While other case studies have focused on how Oregon is aligning its health care and early learning systems, this case study focuses on collaboration between Medicaid and public health in Oregon to improve health outcomes for a geographically defined population.

 

Download the graphic below and share it on social media!

 

DOI

https://doi.org/10.31478/201704f

Suggested Citation

Bonney, J. and D. I. Chang. 2017. Case Study: Medicaid and Public Health Collaboration in Oregon. NAM Perspectives. Discussion Paper, National Academy of Medicine, Washington, DC. doi: 10.31478/201704f


Note

Disclaimer: The views expressed in this paper are those of the authors and not necessarily of the authors’ organizations, the National Academy of Medicine (NAM), or the National Academies of Sciences, Engineering, and Medicine (the National Academies). The paper is intended to help inform and stimulate discussion. It is not a report of the NAM or the National Academies. Copyright by the National Academy of Sciences. All rights reserved.